Reunion Neuroscience Stock Z Score
| REUNDelisted Stock | USD 1.12 0.01 0.90% |
Reunion |
Reunion Neuroscience Company Z Score Analysis
Reunion Neuroscience's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Reunion Neuroscience Z Score | -3.04 |
Most of Reunion Neuroscience's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reunion Neuroscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Reunion Neuroscience has a Z Score of -3.04. This is 145.04% lower than that of the Healthcare sector and 191.02% lower than that of the Biotechnology industry. The z score for all United States stocks is 134.86% higher than that of the company.
Reunion Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reunion Neuroscience's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Reunion Neuroscience could also be used in its relative valuation, which is a method of valuing Reunion Neuroscience by comparing valuation metrics of similar companies.Reunion Neuroscience is currently under evaluation in z score category among its peers.
Reunion Fundamentals
| Return On Equity | -0.86 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | (13.96 M) | |||
| Shares Outstanding | 11.72 M | |||
| Shares Owned By Insiders | 34.39 % | |||
| Shares Owned By Institutions | 50.65 % | |||
| Number Of Shares Shorted | 114.9 K | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 2.80 X | |||
| Gross Profit | (4.29 M) | |||
| EBITDA | (17.15 M) | |||
| Net Income | (48.49 M) | |||
| Cash And Equivalents | 48.13 M | |||
| Cash Per Share | 4.14 X | |||
| Total Debt | 3.37 M | |||
| Current Ratio | 47.74 X | |||
| Book Value Per Share | 1.82 X | |||
| Cash Flow From Operations | (27.92 M) | |||
| Short Ratio | 1.92 X | |||
| Earnings Per Share | (2.51) X | |||
| Target Price | 9.39 | |||
| Number Of Employees | 16 | |||
| Beta | 4.21 | |||
| Market Capitalization | 13.01 M | |||
| Total Asset | 29.74 M | |||
| Retained Earnings | (91.48 M) | |||
| Working Capital | 21.24 M | |||
| Z Score | -3.04 | |||
| Net Asset | 29.74 M |
About Reunion Neuroscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reunion Neuroscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reunion Neuroscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reunion Neuroscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Reunion Neuroscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Reunion Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will appreciate offsetting losses from the drop in the long position's value.Moving against Reunion Stock
| 0.86 | CSLLY | CSL | PairCorr |
| 0.83 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.82 | CMXHF | CSL Limited | PairCorr |
| 0.71 | QSAM | Qsam Biosciences | PairCorr |
| 0.7 | NVO | Novo Nordisk AS | PairCorr |
The ability to find closely correlated positions to Reunion Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reunion Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reunion Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reunion Neuroscience to buy it.
The correlation of Reunion Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Reunion Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Reunion Stock
If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |